Breaking News Instant updates and real-time market news.

SYK

Stryker

$151.76

-0.27 (-0.18%)

, ENTL

Entellus Medical

$16.01

-0.25 (-1.54%)

08:28
12/07/17
12/07
08:28
12/07/17
08:28

Stryker sees Entellus Medical acquisition dilutive by 4c to FY18 adj. EPS

Stryker (SYK) announced a definitive merger agreement to acquire Entellus Medical (ENTL) for $24.00 per share, or an equity value of approximately $662M. The transaction is expected to be dilutive to Stryker's 2018 adjusted net EPS by approximately 4c and accretive thereafter.

SYK

Stryker

$151.76

-0.27 (-0.18%)

ENTL

Entellus Medical

$16.01

-0.25 (-1.54%)

  • 12

    Dec

  • 13

    Dec

SYK Stryker
$151.76

-0.27 (-0.18%)

11/16/17
BARD
11/16/17
UPGRADE
Target $173
BARD
Outperform
Stryker upgraded to Outperform at Baird
As reported previously, Baird analyst Jeff Johnson upgraded Stryker to Outperform from Neutral reflecting his conviction in the company's ability to deliver double digit EBIT and earnings growth in 2018 based on the firm's positive hospital capital expenditure survey results and growing evidence of accelerating Mako total knee training efforts over the past month or two. Johnson raised his price target to $173 from $161 on Stryker shares.
11/16/17
BARD
11/16/17
UPGRADE
BARD
Outperform
Stryker upgraded to Outperform from Neutral at Baird
10/31/17
OPCO
10/31/17
NO CHANGE
Target $156
OPCO
Outperform
Stryker price target raised to $156 from $148 at Oppenheimer
Oppenheimer analyst Steven Lichtman raised his price target for Stryker to $156 from $148 on higher estimates following quarterly results. The analyst reiterates an Outperform rating on the shares.
10/27/17
COWN
10/27/17
NO CHANGE
Target $166
COWN
Outperform
Stryker Q3 results solid despite challenges, says Cowen
Cowen analyst Joshua Jennings said Stryker reported solid Q3 results despite challenges from a Sage ship-hold and bad weather. The analyst said he is encouraged by the company's increased guidance as margins remain on track. Jennings reiterated his Outperform rating and raised his price target to $166 from $160 on Stryker shares.
ENTL Entellus Medical
$16.01

-0.25 (-1.54%)

05/04/17
ADAM
05/04/17
DOWNGRADE
Target $18
ADAM
Hold
Entellus Medical downgraded to Hold from Buy at Canaccord
Canaccord analyst Kyle Rose downgraded Entellus Medical to Hold from Buy and lowered its price target to $18 from $22 saying the soft Q1 report indicates a slowing in the core US business.
02/22/17
BOFA
02/22/17
DOWNGRADE
BOFA
Underperform
Entellus Medical downgraded to Underperform from Buy at BofA/Merrill
02/22/17
BTIG
02/22/17
DOWNGRADE
BTIG
Neutral
Entellus Medical downgraded to Neutral from Buy at BTIG
BTIG analyst Sean Lavin downgraded Entellus Medical to Neutral after the company guided to14%-20% 2017 growth and a larger loss than consensus. "Something has gone off course," the analyst writes in a post-earnings research note. He believes the "business is changing."
12/13/16
PIPR
12/13/16
NO CHANGE
Target $21
PIPR
Overweight
Piper says NICE support of XprESS should help Entellus international growth
After NICE published its recommendation in support of Entellus Medical's XprESS multi-sinus dilation system, Piper Jaffray analyst Matt O'Brien called the news a positive that should help drive adoption outside of the U.S. and support the company's international growth goals. He keeps an Overweight rating and $21 price target on Entellus shares.

TODAY'S FREE FLY STORIES

PDD

Pinduoduo

$23.78

0.63 (2.72%)

15:30
11/21/18
11/21
15:30
11/21/18
15:30
Options
Put sellers in Pinduoduo as shares extend gains »

Put sellers in Pinduoduo…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$177.75

0.65 (0.37%)

, AMZN

Amazon.com

$1,523.71

28.11 (1.88%)

15:29
11/21/18
11/21
15:29
11/21/18
15:29
Periodicals
Apple weighed new connected TV 'dongle,' Information reports »

Apple (AAPL) has held…

AAPL

Apple

$177.75

0.65 (0.37%)

AMZN

Amazon.com

$1,523.71

28.11 (1.88%)

GOOG

Alphabet

$1,044.26

18.26 (1.78%)

GOOGL

Alphabet Class A

$1,050.29

19.07 (1.85%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

  • 04

    Dec

  • 04

    Dec

  • 03

    Mar

TSRO

Tesaro

$43.63

1.15 (2.71%)

15:25
11/21/18
11/21
15:25
11/21/18
15:25
Options
TESARO call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Dec

GME

GameStop

$13.72

1.42 (11.54%)

15:22
11/21/18
11/21
15:22
11/21/18
15:22
Recommendations
GameStop analyst commentary  »

GameStop sale of Spring…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Nov

ESRX

Express Scripts

$95.91

0.61 (0.64%)

, CI

Cigna

$210.99

3.09 (1.49%)

15:18
11/21/18
11/21
15:18
11/21/18
15:18
Hot Stocks
NYDFS to hold hearing on Cigna deal for Express Scripts on December 7 »

The New York State…

ESRX

Express Scripts

$95.91

0.61 (0.64%)

CI

Cigna

$210.99

3.09 (1.49%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

15:17
11/21/18
11/21
15:17
11/21/18
15:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

15:16
11/21/18
11/21
15:16
11/21/18
15:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NUS

Nu Skin

$66.17

0.75 (1.15%)

15:14
11/21/18
11/21
15:14
11/21/18
15:14
Recommendations
Nu Skin analyst commentary  »

Nu Skin pullback a buying…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QD

Qudian

$5.38

1.08 (25.12%)

15:10
11/21/18
11/21
15:10
11/21/18
15:10
Options
Call buyers in Qudian as shares rally 24% »

Call buyers in Qudian as…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

HDSN

Hudson Technologies

$1.13

0.04 (3.67%)

15:04
11/21/18
11/21
15:04
11/21/18
15:04
Options
Hudson Technologies options imply 31.1% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ABX

Barrick Gold

$13.52

0.5 (3.84%)

15:00
11/21/18
11/21
15:00
11/21/18
15:00
Options
Size Reverse/Conversion trade in Barrick Gold suggests stock replacement »

Size Reverse/Conversion…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OIH

Oil Services Holders Trust

$18.87

0.37 (2.00%)

14:50
11/21/18
11/21
14:50
11/21/18
14:50
Options
Active trading in VanEck Vectors Oil Services 20-strike calls »

Active trading in VanEck…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMZN

Amazon.com

$1,529.99

34.39 (2.30%)

14:50
11/21/18
11/21
14:50
11/21/18
14:50
Periodicals
NYC officials say half of Queens Amazon jobs won't be in tech, WSJ says »

New York City officials…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

  • 04

    Dec

SQM

SQM

$43.70

1.825 (4.36%)

14:49
11/21/18
11/21
14:49
11/21/18
14:49
Options
SQM options imply 8.5% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

14:45
11/21/18
11/21
14:45
11/21/18
14:45
General news
Treasury Closing Summary: »

Treasury Closing Summary:…

CBFV

CB Financial Services

$25.79

(0.00%)

14:42
11/21/18
11/21
14:42
11/21/18
14:42
Hot Stocks
CB Financial Services increases dividend by 4.5% to 23c per share »

CB Financial Services,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BECN

Beacon Roofing

$32.94

4.87 (17.35%)

14:28
11/21/18
11/21
14:28
11/21/18
14:28
Hot Stocks
CD&R Group to buy additional shares in Beacon Roofing »

In a regulatory filing…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

NTN

NTN Buzztime

$2.70

-0.1 (-3.57%)

14:26
11/21/18
11/21
14:26
11/21/18
14:26
Hot Stocks
Northstar reports 10.33% stake in NTN Buzztime »

On November 21, Northstar…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

14:23
11/21/18
11/21
14:23
11/21/18
14:23
Conference/Events
The U.S. Commodity Futures Trading Commission to hold a podcast »

The Commodity Futures…

RHHBY

Roche

$0.00

(0.00%)

, ABBV

AbbVie

$85.75

-2.35 (-2.67%)

14:18
11/21/18
11/21
14:18
11/21/18
14:18
Hot Stocks
Roche announces FDA grants accelerated approval for Venclexta combo »

Roche (RHHBY) announced…

RHHBY

Roche

$0.00

(0.00%)

ABBV

AbbVie

$85.75

-2.35 (-2.67%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Dec

  • 03

    Dec

  • 24

    Dec

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

14:17
11/21/18
11/21
14:17
11/21/18
14:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ABBV

AbbVie

$85.70

-2.4 (-2.72%)

, RHHBY

Roche

$0.00

(0.00%)

14:16
11/21/18
11/21
14:16
11/21/18
14:16
Hot Stocks
AbbVie says FDA grants accelerated approval to Venclexta-azacitidine combo »

AbbVie (ABBV) announced…

ABBV

AbbVie

$85.70

-2.4 (-2.72%)

RHHBY

Roche

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Dec

  • 03

    Dec

  • 24

    Dec

$NYE

NYSE Market Internals

$0.00

(0.00%)

14:16
11/21/18
11/21
14:16
11/21/18
14:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WPP

WPP

$54.99

1.4 (2.61%)

14:15
11/21/18
11/21
14:15
11/21/18
14:15
Periodicals
Martin Sorrell to poach senior executive from WPP, Sky News reports »

Martin Sorrell is to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Dec

TGT

Target

$69.10

0.05 (0.07%)

14:10
11/21/18
11/21
14:10
11/21/18
14:10
Options
Target calls lead puts 3:1 after a big drop in shares »

Target calls lead puts…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Mar

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.